Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Potassium Sodium Dehydroandrographolide Succinate for Injection Market Growth 2022-2028

  • LP 4979579
  • 101 Pages
  • August 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Potassium Sodium Dehydroandrographolide Succinate for Injection will have significant change from previous year. According to our (LP Information) latest study, the global Potassium Sodium Dehydroandrographolide Succinate for Injection market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Potassium Sodium Dehydroandrographolide Succinate for Injection market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Potassium Sodium Dehydroandrographolide Succinate for Injection market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Potassium Sodium Dehydroandrographolide Succinate for Injection market, reaching US$ million by the year 2028. As for the Europe Potassium Sodium Dehydroandrographolide Succinate for Injection landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Potassium Sodium Dehydroandrographolide Succinate for Injection players cover Shanxi PUDE Pharmaceutical, Chengdu Tiantai Mountain Pharmaceutical, Beijing SL Pharmaceutical, and Yaopharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Potassium Sodium Dehydroandrographolide Succinate for Injection market by product type, application, key manufacturers and key regions and countries.

Segmentation by specification: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

40mg/Bottle

80mg/Bottle

200mg/Bottle

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospital Pharmacy

Retail Pharmacy

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Shanxi PUDE Pharmaceutical

Chengdu Tiantai Mountain Pharmaceutical

Beijing SL Pharmaceutical

Yaopharma

Sinopharm Guorui Pharmaceutical

Reyoung Pharmaceutical

Fujian Mindong Rejuenation Pharmaceutical

Chongqing Lummy Pharmaceutical

Youcare Pharmaceutical

Haikou Qili Pharmaceutical

Harbin Medisan Pharmaceutical

Hainan Hualon Pharmaceutical

Anhui Hongye Pharmaceutical

Guangzhou Invin Pharmaceutical

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Potassium Sodium Dehydroandrographolide Succinate for Injection Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Potassium Sodium Dehydroandrographolide Succinate for Injection by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Potassium Sodium Dehydroandrographolide Succinate for Injection by Country/Region, 2017, 2022 & 2028

2.2 Potassium Sodium Dehydroandrographolide Succinate for Injection Segment by Specification

2.2.1 40mg/Bottle

2.2.2 80mg/Bottle

2.2.3 200mg/Bottle

2.3 Potassium Sodium Dehydroandrographolide Succinate for Injection Sales by Specification

2.3.1 Global Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Market Share by Specification (2017-2022)

2.3.2 Global Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue and Market Share by Specification (2017-2022)

2.3.3 Global Potassium Sodium Dehydroandrographolide Succinate for Injection Sale Price by Specification (2017-2022)

2.4 Potassium Sodium Dehydroandrographolide Succinate for Injection Segment by Application

2.4.1 Hospital Pharmacy

2.4.2 Retail Pharmacy

2.4.3 Others

2.5 Potassium Sodium Dehydroandrographolide Succinate for Injection Sales by Application

2.5.1 Global Potassium Sodium Dehydroandrographolide Succinate for Injection Sale Market Share by Application (2017-2022)

2.5.2 Global Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue and Market Share by Application (2017-2022)

2.5.3 Global Potassium Sodium Dehydroandrographolide Succinate for Injection Sale Price by Application (2017-2022)

3 Global Potassium Sodium Dehydroandrographolide Succinate for Injection by Company

3.1 Global Potassium Sodium Dehydroandrographolide Succinate for Injection Breakdown Data by Company

3.1.1 Global Potassium Sodium Dehydroandrographolide Succinate for Injection Annual Sales by Company (2020-2022)

3.1.2 Global Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Market Share by Company (2020-2022)

3.2 Global Potassium Sodium Dehydroandrographolide Succinate for Injection Annual Revenue by Company (2020-2022)

3.2.1 Global Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue by Company (2020-2022)

3.2.2 Global Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Market Share by Company (2020-2022)

3.3 Global Potassium Sodium Dehydroandrographolide Succinate for Injection Sale Price by Company

3.4 Key Manufacturers Potassium Sodium Dehydroandrographolide Succinate for Injection Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Potassium Sodium Dehydroandrographolide Succinate for Injection Product Location Distribution

3.4.2 Players Potassium Sodium Dehydroandrographolide Succinate for Injection Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Potassium Sodium Dehydroandrographolide Succinate for Injection by Geographic Region

4.1 World Historic Potassium Sodium Dehydroandrographolide Succinate for Injection Market Size by Geographic Region (2017-2022)

4.1.1 Global Potassium Sodium Dehydroandrographolide Succinate for Injection Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Potassium Sodium Dehydroandrographolide Succinate for Injection Annual Revenue by Geographic Region

4.2 World Historic Potassium Sodium Dehydroandrographolide Succinate for Injection Market Size by Country/Region (2017-2022)

4.2.1 Global Potassium Sodium Dehydroandrographolide Succinate for Injection Annual Sales by Country/Region (2017-2022)

4.2.2 Global Potassium Sodium Dehydroandrographolide Succinate for Injection Annual Revenue by Country/Region

4.3 Americas Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Growth

4.4 APAC Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Growth

4.5 Europe Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Growth

4.6 Middle East & Africa Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Growth

5 Americas

5.1 Americas Potassium Sodium Dehydroandrographolide Succinate for Injection Sales by Country

5.1.1 Americas Potassium Sodium Dehydroandrographolide Succinate for Injection Sales by Country (2017-2022)

5.1.2 Americas Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue by Country (2017-2022)

5.2 Americas Potassium Sodium Dehydroandrographolide Succinate for Injection Sales by Specification

5.3 Americas Potassium Sodium Dehydroandrographolide Succinate for Injection Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Potassium Sodium Dehydroandrographolide Succinate for Injection Sales by Region

6.1.1 APAC Potassium Sodium Dehydroandrographolide Succinate for Injection Sales by Region (2017-2022)

6.1.2 APAC Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue by Region (2017-2022)

6.2 APAC Potassium Sodium Dehydroandrographolide Succinate for Injection Sales by Specification

6.3 APAC Potassium Sodium Dehydroandrographolide Succinate for Injection Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Potassium Sodium Dehydroandrographolide Succinate for Injection by Country

7.1.1 Europe Potassium Sodium Dehydroandrographolide Succinate for Injection Sales by Country (2017-2022)

7.1.2 Europe Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue by Country (2017-2022)

7.2 Europe Potassium Sodium Dehydroandrographolide Succinate for Injection Sales by Specification

7.3 Europe Potassium Sodium Dehydroandrographolide Succinate for Injection Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Potassium Sodium Dehydroandrographolide Succinate for Injection by Country

8.1.1 Middle East & Africa Potassium Sodium Dehydroandrographolide Succinate for Injection Sales by Country (2017-2022)

8.1.2 Middle East & Africa Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue by Country (2017-2022)

8.2 Middle East & Africa Potassium Sodium Dehydroandrographolide Succinate for Injection Sales by Specification

8.3 Middle East & Africa Potassium Sodium Dehydroandrographolide Succinate for Injection Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Potassium Sodium Dehydroandrographolide Succinate for Injection

10.3 Manufacturing Process Analysis of Potassium Sodium Dehydroandrographolide Succinate for Injection

10.4 Industry Chain Structure of Potassium Sodium Dehydroandrographolide Succinate for Injection

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Potassium Sodium Dehydroandrographolide Succinate for Injection Distributors

11.3 Potassium Sodium Dehydroandrographolide Succinate for Injection Customer

12 World Forecast Review for Potassium Sodium Dehydroandrographolide Succinate for Injection by Geographic Region

12.1 Global Potassium Sodium Dehydroandrographolide Succinate for Injection Market Size Forecast by Region

12.1.1 Global Potassium Sodium Dehydroandrographolide Succinate for Injection Forecast by Region (2023-2028)

12.1.2 Global Potassium Sodium Dehydroandrographolide Succinate for Injection Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Potassium Sodium Dehydroandrographolide Succinate for Injection Forecast by Specification

12.7 Global Potassium Sodium Dehydroandrographolide Succinate for Injection Forecast by Application

13 Key Players Analysis

13.1 Shanxi PUDE Pharmaceutical

13.1.1 Shanxi PUDE Pharmaceutical Company Information

13.1.2 Shanxi PUDE Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Product Offered

13.1.3 Shanxi PUDE Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Shanxi PUDE Pharmaceutical Main Business Overview

13.1.5 Shanxi PUDE Pharmaceutical Latest Developments

13.2 Chengdu Tiantai Mountain Pharmaceutical

13.2.1 Chengdu Tiantai Mountain Pharmaceutical Company Information

13.2.2 Chengdu Tiantai Mountain Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Product Offered

13.2.3 Chengdu Tiantai Mountain Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Chengdu Tiantai Mountain Pharmaceutical Main Business Overview

13.2.5 Chengdu Tiantai Mountain Pharmaceutical Latest Developments

13.3 Beijing SL Pharmaceutical

13.3.1 Beijing SL Pharmaceutical Company Information

13.3.2 Beijing SL Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Product Offered

13.3.3 Beijing SL Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Beijing SL Pharmaceutical Main Business Overview

13.3.5 Beijing SL Pharmaceutical Latest Developments

13.4 Yaopharma

13.4.1 Yaopharma Company Information

13.4.2 Yaopharma Potassium Sodium Dehydroandrographolide Succinate for Injection Product Offered

13.4.3 Yaopharma Potassium Sodium Dehydroandrographolide Succinate for Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Yaopharma Main Business Overview

13.4.5 Yaopharma Latest Developments

13.5 Sinopharm Guorui Pharmaceutical

13.5.1 Sinopharm Guorui Pharmaceutical Company Information

13.5.2 Sinopharm Guorui Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Product Offered

13.5.3 Sinopharm Guorui Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Sinopharm Guorui Pharmaceutical Main Business Overview

13.5.5 Sinopharm Guorui Pharmaceutical Latest Developments

13.6 Reyoung Pharmaceutical

13.6.1 Reyoung Pharmaceutical Company Information

13.6.2 Reyoung Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Product Offered

13.6.3 Reyoung Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Reyoung Pharmaceutical Main Business Overview

13.6.5 Reyoung Pharmaceutical Latest Developments

13.7 Fujian Mindong Rejuenation Pharmaceutical

13.7.1 Fujian Mindong Rejuenation Pharmaceutical Company Information

13.7.2 Fujian Mindong Rejuenation Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Product Offered

13.7.3 Fujian Mindong Rejuenation Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Fujian Mindong Rejuenation Pharmaceutical Main Business Overview

13.7.5 Fujian Mindong Rejuenation Pharmaceutical Latest Developments

13.8 Chongqing Lummy Pharmaceutical

13.8.1 Chongqing Lummy Pharmaceutical Company Information

13.8.2 Chongqing Lummy Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Product Offered

13.8.3 Chongqing Lummy Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Chongqing Lummy Pharmaceutical Main Business Overview

13.8.5 Chongqing Lummy Pharmaceutical Latest Developments

13.9 Youcare Pharmaceutical

13.9.1 Youcare Pharmaceutical Company Information

13.9.2 Youcare Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Product Offered

13.9.3 Youcare Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Youcare Pharmaceutical Main Business Overview

13.9.5 Youcare Pharmaceutical Latest Developments

13.10 Haikou Qili Pharmaceutical

13.10.1 Haikou Qili Pharmaceutical Company Information

13.10.2 Haikou Qili Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Product Offered

13.10.3 Haikou Qili Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Haikou Qili Pharmaceutical Main Business Overview

13.10.5 Haikou Qili Pharmaceutical Latest Developments

13.11 Harbin Medisan Pharmaceutical

13.11.1 Harbin Medisan Pharmaceutical Company Information

13.11.2 Harbin Medisan Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Product Offered

13.11.3 Harbin Medisan Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Harbin Medisan Pharmaceutical Main Business Overview

13.11.5 Harbin Medisan Pharmaceutical Latest Developments

13.12 Hainan Hualon Pharmaceutical

13.12.1 Hainan Hualon Pharmaceutical Company Information

13.12.2 Hainan Hualon Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Product Offered

13.12.3 Hainan Hualon Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Hainan Hualon Pharmaceutical Main Business Overview

13.12.5 Hainan Hualon Pharmaceutical Latest Developments

13.13 Anhui Hongye Pharmaceutical

13.13.1 Anhui Hongye Pharmaceutical Company Information

13.13.2 Anhui Hongye Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Product Offered

13.13.3 Anhui Hongye Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Anhui Hongye Pharmaceutical Main Business Overview

13.13.5 Anhui Hongye Pharmaceutical Latest Developments

13.14 Guangzhou Invin Pharmaceutical

13.14.1 Guangzhou Invin Pharmaceutical Company Information

13.14.2 Guangzhou Invin Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Product Offered

13.14.3 Guangzhou Invin Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Guangzhou Invin Pharmaceutical Main Business Overview

13.14.5 Guangzhou Invin Pharmaceutical Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Potassium Sodium Dehydroandrographolide Succinate for Injection Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Potassium Sodium Dehydroandrographolide Succinate for Injection Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 40mg/Bottle

Table 4. Major Players of 80mg/Bottle

Table 5. Major Players of 200mg/Bottle

Table 6. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Sales by Specification (2017-2022) & (K Units)

Table 7. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Market Share by Specification (2017-2022)

Table 8. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue by Specification (2017-2022) & ($ million)

Table 9. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Market Share by Specification (2017-2022)

Table 10. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Sale Price by Specification (2017-2022) & (US$/Unit)

Table 11. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Sales by Application (2017-2022) & (K Units)

Table 12. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Market Share by Application (2017-2022)

Table 13. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue by Application (2017-2022)

Table 14. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Market Share by Application (2017-2022)

Table 15. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Sale Price by Application (2017-2022) & (US$/Unit)

Table 16. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Sales by Company (2020-2022) & (K Units)

Table 17. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Market Share by Company (2020-2022)

Table 18. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Market Share by Company (2020-2022)

Table 20. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Sale Price by Company (2020-2022) & (US$/Unit)

Table 21. Key Manufacturers Potassium Sodium Dehydroandrographolide Succinate for Injection Producing Area Distribution and Sales Area

Table 22. Players Potassium Sodium Dehydroandrographolide Succinate for Injection Products Offered

Table 23. Potassium Sodium Dehydroandrographolide Succinate for Injection Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Market Share Geographic Region (2017-2022)

Table 28. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Market Share by Country/Region (2017-2022)

Table 32. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Potassium Sodium Dehydroandrographolide Succinate for Injection Sales by Country (2017-2022) & (K Units)

Table 35. Americas Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Market Share by Country (2017-2022)

Table 36. Americas Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Market Share by Country (2017-2022)

Table 38. Americas Potassium Sodium Dehydroandrographolide Succinate for Injection Sales by Type (2017-2022) & (K Units)

Table 39. Americas Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Market Share by Specification (2017-2022)

Table 40. Americas Potassium Sodium Dehydroandrographolide Succinate for Injection Sales by Application (2017-2022) & (K Units)

Table 41. Americas Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Market Share by Application (2017-2022)

Table 42. APAC Potassium Sodium Dehydroandrographolide Succinate for Injection Sales by Region (2017-2022) & (K Units)

Table 43. APAC Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Market Share by Region (2017-2022)

Table 44. APAC Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Market Share by Region (2017-2022)

Table 46. APAC Potassium Sodium Dehydroandrographolide Succinate for Injection Sales by Specification (2017-2022) & (K Units)

Table 47. APAC Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Market Share by Specification (2017-2022)

Table 48. APAC Potassium Sodium Dehydroandrographolide Succinate for Injection Sales by Application (2017-2022) & (K Units)

Table 49. APAC Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Market Share by Application (2017-2022)

Table 50. Europe Potassium Sodium Dehydroandrographolide Succinate for Injection Sales by Country (2017-2022) & (K Units)

Table 51. Europe Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Market Share by Country (2017-2022)

Table 52. Europe Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Market Share by Country (2017-2022)

Table 54. Europe Potassium Sodium Dehydroandrographolide Succinate for Injection Sales by Type (2017-2022) & (K Units)

Table 55. Europe Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Market Share by Specification (2017-2022)

Table 56. Europe Potassium Sodium Dehydroandrographolide Succinate for Injection Sales by Application (2017-2022) & (K Units)

Table 57. Europe Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Potassium Sodium Dehydroandrographolide Succinate for Injection Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Potassium Sodium Dehydroandrographolide Succinate for Injection Sales by Specification (2017-2022) & (K Units)

Table 63. Middle East & Africa Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Market Share by Specification (2017-2022)

Table 64. Middle East & Africa Potassium Sodium Dehydroandrographolide Succinate for Injection Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Potassium Sodium Dehydroandrographolide Succinate for Injection

Table 67. Key Market Challenges & Risks of Potassium Sodium Dehydroandrographolide Succinate for Injection

Table 68. Key Industry Trends of Potassium Sodium Dehydroandrographolide Succinate for Injection

Table 69. Potassium Sodium Dehydroandrographolide Succinate for Injection Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Potassium Sodium Dehydroandrographolide Succinate for Injection Distributors List

Table 72. Potassium Sodium Dehydroandrographolide Succinate for Injection Customer List

Table 73. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Market Forecast by Region

Table 75. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Forecast by Specification (2023-2028) & (K Units)

Table 86. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Market Share Forecast by Specification (2023-2028)

Table 87. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Forecast by Specification (2023-2028) & ($ Millions)

Table 88. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Market Share Forecast by Specification (2023-2028)

Table 89. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Market Share Forecast by Application (2023-2028)

Table 93. Shanxi PUDE Pharmaceutical Basic Information, Potassium Sodium Dehydroandrographolide Succinate for Injection Manufacturing Base, Sales Area and Its Competitors

Table 94. Shanxi PUDE Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Product Offered

Table 95. Shanxi PUDE Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 96. Shanxi PUDE Pharmaceutical Main Business

Table 97. Shanxi PUDE Pharmaceutical Latest Developments

Table 98. Chengdu Tiantai Mountain Pharmaceutical Basic Information, Potassium Sodium Dehydroandrographolide Succinate for Injection Manufacturing Base, Sales Area and Its Competitors

Table 99. Chengdu Tiantai Mountain Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Product Offered

Table 100. Chengdu Tiantai Mountain Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 101. Chengdu Tiantai Mountain Pharmaceutical Main Business

Table 102. Chengdu Tiantai Mountain Pharmaceutical Latest Developments

Table 103. Beijing SL Pharmaceutical Basic Information, Potassium Sodium Dehydroandrographolide Succinate for Injection Manufacturing Base, Sales Area and Its Competitors

Table 104. Beijing SL Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Product Offered

Table 105. Beijing SL Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 106. Beijing SL Pharmaceutical Main Business

Table 107. Beijing SL Pharmaceutical Latest Developments

Table 108. Yaopharma Basic Information, Potassium Sodium Dehydroandrographolide Succinate for Injection Manufacturing Base, Sales Area and Its Competitors

Table 109. Yaopharma Potassium Sodium Dehydroandrographolide Succinate for Injection Product Offered

Table 110. Yaopharma Potassium Sodium Dehydroandrographolide Succinate for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 111. Yaopharma Main Business

Table 112. Yaopharma Latest Developments

Table 113. Sinopharm Guorui Pharmaceutical Basic Information, Potassium Sodium Dehydroandrographolide Succinate for Injection Manufacturing Base, Sales Area and Its Competitors

Table 114. Sinopharm Guorui Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Product Offered

Table 115. Sinopharm Guorui Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 116. Sinopharm Guorui Pharmaceutical Main Business

Table 117. Sinopharm Guorui Pharmaceutical Latest Developments

Table 118. Reyoung Pharmaceutical Basic Information, Potassium Sodium Dehydroandrographolide Succinate for Injection Manufacturing Base, Sales Area and Its Competitors

Table 119. Reyoung Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Product Offered

Table 120. Reyoung Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 121. Reyoung Pharmaceutical Main Business

Table 122. Reyoung Pharmaceutical Latest Developments

Table 123. Fujian Mindong Rejuenation Pharmaceutical Basic Information, Potassium Sodium Dehydroandrographolide Succinate for Injection Manufacturing Base, Sales Area and Its Competitors

Table 124. Fujian Mindong Rejuenation Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Product Offered

Table 125. Fujian Mindong Rejuenation Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 126. Fujian Mindong Rejuenation Pharmaceutical Main Business

Table 127. Fujian Mindong Rejuenation Pharmaceutical Latest Developments

Table 128. Chongqing Lummy Pharmaceutical Basic Information, Potassium Sodium Dehydroandrographolide Succinate for Injection Manufacturing Base, Sales Area and Its Competitors

Table 129. Chongqing Lummy Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Product Offered

Table 130. Chongqing Lummy Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 131. Chongqing Lummy Pharmaceutical Main Business

Table 132. Chongqing Lummy Pharmaceutical Latest Developments

Table 133. Youcare Pharmaceutical Basic Information, Potassium Sodium Dehydroandrographolide Succinate for Injection Manufacturing Base, Sales Area and Its Competitors

Table 134. Youcare Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Product Offered

Table 135. Youcare Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 136. Youcare Pharmaceutical Main Business

Table 137. Youcare Pharmaceutical Latest Developments

Table 138. Haikou Qili Pharmaceutical Basic Information, Potassium Sodium Dehydroandrographolide Succinate for Injection Manufacturing Base, Sales Area and Its Competitors

Table 139. Haikou Qili Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Product Offered

Table 140. Haikou Qili Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 141. Haikou Qili Pharmaceutical Main Business

Table 142. Haikou Qili Pharmaceutical Latest Developments

Table 143. Harbin Medisan Pharmaceutical Basic Information, Potassium Sodium Dehydroandrographolide Succinate for Injection Manufacturing Base, Sales Area and Its Competitors

Table 144. Harbin Medisan Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Product Offered

Table 145. Harbin Medisan Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 146. Harbin Medisan Pharmaceutical Main Business

Table 147. Harbin Medisan Pharmaceutical Latest Developments

Table 148. Hainan Hualon Pharmaceutical Basic Information, Potassium Sodium Dehydroandrographolide Succinate for Injection Manufacturing Base, Sales Area and Its Competitors

Table 149. Hainan Hualon Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Product Offered

Table 150. Hainan Hualon Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 151. Hainan Hualon Pharmaceutical Main Business

Table 152. Hainan Hualon Pharmaceutical Latest Developments

Table 153. Anhui Hongye Pharmaceutical Basic Information, Potassium Sodium Dehydroandrographolide Succinate for Injection Manufacturing Base, Sales Area and Its Competitors

Table 154. Anhui Hongye Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Product Offered

Table 155. Anhui Hongye Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 156. Anhui Hongye Pharmaceutical Main Business

Table 157. Anhui Hongye Pharmaceutical Latest Developments

Table 158. Guangzhou Invin Pharmaceutical Basic Information, Potassium Sodium Dehydroandrographolide Succinate for Injection Manufacturing Base, Sales Area and Its Competitors

Table 159. Guangzhou Invin Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Product Offered

Table 160. Guangzhou Invin Pharmaceutical Potassium Sodium Dehydroandrographolide Succinate for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 161. Guangzhou Invin Pharmaceutical Main Business

Table 162. Guangzhou Invin Pharmaceutical Latest Developments

List of Figures

Figure 1. Picture of Potassium Sodium Dehydroandrographolide Succinate for Injection

Figure 2. Potassium Sodium Dehydroandrographolide Succinate for Injection Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Potassium Sodium Dehydroandrographolide Succinate for Injection Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 40mg/Bottle

Figure 10. Product Picture of 80mg/Bottle

Figure 11. Product Picture of 200mg/Bottle

Figure 12. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Market Share by Specification in 2021

Figure 13. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Market Share by Specification (2017-2022)

Figure 14. Potassium Sodium Dehydroandrographolide Succinate for Injection Consumed in Hospital Pharmacy

Figure 15. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Market: Hospital Pharmacy (2017-2022) & (K Units)

Figure 16. Potassium Sodium Dehydroandrographolide Succinate for Injection Consumed in Retail Pharmacy

Figure 17. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Market: Retail Pharmacy (2017-2022) & (K Units)

Figure 18. Potassium Sodium Dehydroandrographolide Succinate for Injection Consumed in Others

Figure 19. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Market: Others (2017-2022) & (K Units)

Figure 20. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Market Share by Application (2017-2022)

Figure 21. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Market Share by Application in 2021

Figure 22. Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Market by Company in 2021 ($ Million)

Figure 23. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Market Share by Company in 2021

Figure 24. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Market Share by Geographic Region (2017-2022)

Figure 25. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Market Share by Geographic Region in 2021

Figure 26. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Market Share by Region (2017-2022)

Figure 27. Global Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Market Share by Country/Region in 2021

Figure 28. Americas Potassium Sodium Dehydroandrographolide Succinate for Injection Sales 2017-2022 (K Units)

Figure 29. Americas Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue 2017-2022 ($ Millions)

Figure 30. APAC Potassium Sodium Dehydroandrographolide Succinate for Injection Sales 2017-2022 (K Units)

Figure 31. APAC Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue 2017-2022 ($ Millions)

Figure 32. Europe Potassium Sodium Dehydroandrographolide Succinate for Injection Sales 2017-2022 (K Units)

Figure 33. Europe Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue 2017-2022 ($ Millions)

Figure 34. Middle East & Africa Potassium Sodium Dehydroandrographolide Succinate for Injection Sales 2017-2022 (K Units)

Figure 35. Middle East & Africa Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue 2017-2022 ($ Millions)

Figure 36. Americas Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Market Share by Country in 2021

Figure 37. Americas Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Market Share by Country in 2021

Figure 38. United States Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Growth 2017-2022 ($ Millions)

Figure 39. Canada Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Growth 2017-2022 ($ Millions)

Figure 40. Mexico Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Growth 2017-2022 ($ Millions)

Figure 41. Brazil Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Growth 2017-2022 ($ Millions)

Figure 42. APAC Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Market Share by Region in 2021

Figure 43. APAC Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Market Share by Regions in 2021

Figure 44. China Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Growth 2017-2022 ($ Millions)

Figure 45. Japan Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Growth 2017-2022 ($ Millions)

Figure 46. South Korea Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Growth 2017-2022 ($ Millions)

Figure 47. Southeast Asia Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Growth 2017-2022 ($ Millions)

Figure 48. India Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Growth 2017-2022 ($ Millions)

Figure 49. Australia Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Growth 2017-2022 ($ Millions)

Figure 50. Europe Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Market Share by Country in 2021

Figure 51. Europe Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Market Share by Country in 2021

Figure 52. Germany Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Growth 2017-2022 ($ Millions)

Figure 53. France Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Growth 2017-2022 ($ Millions)

Figure 54. UK Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Growth 2017-2022 ($ Millions)

Figure 55. Italy Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Growth 2017-2022 ($ Millions)

Figure 56. Russia Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Growth 2017-2022 ($ Millions)

Figure 57. Middle East & Africa Potassium Sodium Dehydroandrographolide Succinate for Injection Sales Market Share by Country in 2021

Figure 58. Middle East & Africa Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Market Share by Country in 2021

Figure 59. Egypt Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Growth 2017-2022 ($ Millions)

Figure 60. South Africa Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Growth 2017-2022 ($ Millions)

Figure 61. Israel Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Growth 2017-2022 ($ Millions)

Figure 62. Turkey Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Growth 2017-2022 ($ Millions)

Figure 63. GCC Country Potassium Sodium Dehydroandrographolide Succinate for Injection Revenue Growth 2017-2022 ($ Millions)

Figure 64. Manufacturing Cost Structure Analysis of Potassium Sodium Dehydroandrographolide Succinate for Injection in 2021

Figure 65. Manufacturing Process Analysis of Potassium Sodium Dehydroandrographolide Succinate for Injection

Figure 66. Industry Chain Structure of Potassium Sodium Dehydroandrographolide Succinate for Injection

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370